Subsequent development of diffuse large B-cell lymphomas and hodgkin lymphoma associated with primary immune disorder in a 6-year-old female: A case report and review of the literature

Marnelli A. Bautista-Quach, Antranik Bedros, Jun Wang

Research output: Contribution to journalReview articlepeer-review

Abstract

Neoplastic lymphoid proliferation may arise from immune deficiency or disordered regulation of the immune system. Often the neoplasms are associated with viral agents, such as Epstein-Barr virus, human immunodeficiency virus, or human herpes virus 8. Lymphoproliferative diseases have been documented in a variety of primary immune disorders. The most commonly encountered neoplastic lesion is diffuse large B-cell lymphoma (DLBCL), although Hodgkin lymphoma (HL), Burkitt lymphoma, and peripheral T-cell lymphomas and/or leukemias have also been documented in rare instances. We report a case of a 6-year-old girl with unclassifiable primary immunodeficiency diagnosed with 2 different clones of DLBCLs and subsequently developed lymphocyte-depleted, classical HL. Both neoplasms were associated with Epstein-Barr virus. To the best of our knowledge, this is the first reported occurrence of primary immune disorder-associated lymphoproliferative disease with sequential development of DLBCLs and HL in a pediatric patient. Thorough surveillance is paramount for accurate assessment of the associated lymphoproliferative disease and in ascertaining likely transformation to, or de novo evolution of a different lymphoid neoplasm. This is also important in evaluating treatment response with appropriate therapeutic adjustments if clinically indicated.

Original languageEnglish
Pages (from-to)e320-e325
JournalJournal of Pediatric Hematology/Oncology
Volume33
Issue number7
DOIs
StatePublished - Oct 2011

ASJC Scopus Subject Areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Keywords

  • Epstein-Barr virus
  • Hodgkin lymphoma
  • diffuse large B-cell lymphoma
  • lymphoproliferative diseases
  • primary immune disorder

Cite this